Description

E-OVA L 2. 5 is a medicine that contains Letrozole as its active ingredient. Letrozole is an aromatase inhibitor, primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the amount of estrogen produced in the body, thereby slowing down the growth of cancer cells. E-OVA L 2. 5 is specifically formulated to aid in the induction of ovulation in women who are suffering from infertility due to anovulation or irregular ovulation. It helps stimulate the release of eggs from the ovaries, increasing the chances of successful conception. E-OVA L 2. 5 should only be used as prescribed and monitored by a healthcare provider. Possible side effects may include hot flashes, vaginal dryness, joint pain, and increased sweating. It is important to consult a doctor before using this medication to ensure its appropriateness and avoid potential drug interactions.

Additional information